Alto Neuroscience, Inc.
For the period ended Dec 31, 2025. Filed Mar 16, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 16, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 3. Legal P
Item 3. Legal Proceedings.
Information pertaining to legal proceedings can be found in Part II of this Annual Report under “Item 8. Financial Statements and Supplementary Data - Note 15. Commitments and Contingencies” and is incorporated by reference herein.
In addition, from time to time, we may be involved in legal proceedings arising in the ordinary course of business. We are not presently a party to any legal proceedings that, in the opinion of management, would have a material adverse effect on our business. Regardless of the outcome, litigation can have an adverse impact on us due to defense and settlement costs, diversion of management resources, negative publicity and reputational harm.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.